AROG4-01

· Aromics Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AROG4-01, covering 2024-11-07 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors [Phase 1]